Postoperative QT interval prolongation in patients undergoing noncardiac surgery under general anesthesia

Anesthesiology

Volumn 117, Issue 2, 2012, Pages 321-328

  Nagele, Peter ^a   Pal, Swatilika ^a   Brown, Frank ^b   Blood, Jane ^a   Miller, J Philipp ^b   Johnston, Joshua ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CALCIUM; CEFOXITIN; EPHEDRINE; ISOFLURANE; KETOROLAC; MAGNESIUM; METHADONE; PIPERACILLIN PLUS TAZOBACTAM; POTASSIUM; SULTAMICILLIN;

AGED; ARTICLE; BODY TEMPERATURE; ELECTROCARDIOGRAPHY; FEMALE; GENERAL ANESTHESIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MINERAL BLOOD LEVEL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QT PROLONGATION; TORSADE DES POINTES; TREATMENT OUTCOME;

AGED; ANALGESICS, OPIOID; ANESTHESIA, GENERAL; ANESTHETICS, GENERAL; ANESTHETICS, INHALATION; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; LONG QT SYNDROME; MALE; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, OPERATIVE; TORSADES DE POINTES; VASOCONSTRICTOR AGENTS;

EID: 84864282629     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31825e6eb3     Document Type: Article

References (30)

1. van der Heide K, de Haes A, Wietasch GJ, Wiesfeld AC, Hendriks HG: Torsades de pointes during laparoscopic adrenalectomy of a pheochromocytoma: A case report. J Med Case Rep 2011; 5:368.
2. Tajiri O, Ito H, Yago Y, Masumori Y: [Torsade de pointes (TdP) observed during general anesthesia for cerebral aneurysm clipping in a patient with QT prolongation]. Masui 2011; 60:1090-3.
3. Tacken MC, Bracke FA, Van Zundert AA: Torsade de pointes during sevoflurane anesthesia and fluconazole infusion in a patient with long QT syndrome. A case report. Acta Anaesthesiol Belg 2011; 62:105-8.
4. Mandal B, Kaur G, Batra YK, Mahajan S: Manifestation of Long QT syndrome with normal QTc interval under anesthesia: A case report. Paediatr Anaesth 2011; 21:1265-7.
5. Lee JY, Lee JH, An EH, Song JG, Park PH: Postanesthetic torsade de pointes in a patient with unrecognized long QT syndrome: A case report. Korean J Anesthesiol 2011; 60: 294-7.
6. Hamaguchi E, Kawano H, Kawahito S, Kitahata H, Oshita S: [Torsade de pointes associated with severe bradycardia after induction of general anesthesia]. Masui 2011; 60:1097-100.
7. Roden DM: Clinical practice. Long-QT syndrome. N Engl J Med 2008; 358:169-76.
8. Pollard CE, Abi Gerges N, Bridgland-Taylor MH, Easter A, Hammond TG, Valentin JP: An introduction to QT interval prolongation and non-clinical approaches to assessing and reducing risk. Br J Pharmacol 2010; 159:12-21.
9. Roden DM: Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350:1013-22.
10. Kannankeril P, Roden DM, Darbar D: Drug-induced long QT syndrome. Pharmacol Rev 2010; 62:760-81.
11. Heist EK, Ruskin JN: Drug-induced arrhythmia. Circulation 2010; 122:1426-35.
12. Smithburger PL, Seybert AL, Armahizer MJ, Kane-Gill SL: QT prolongation in the intensive care unit: Commonly used medications and the impact of drug-drug interactions. Expert Opin Drug Safety 2010; 9:699-712.
13. Charbit B, Albaladejo P, Funck-Brentano C, Legrand M, Samain E, Marty J: Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 2005; 102:1094-100.
14. Han DW, Park K, Jang SB, Kern SE: Modeling the effect of sevoflurane on corrected QT prolongation: A pharmacodynamic analysis. Anesthesiology 2010; 113:806-11.
15. Curry TB, Gaver R, White RD: Acquired long QT syndrome and elective anesthesia in children. Paediatr Anaesth 2006; 16:471-8.
16. Darpo B, Nebout T, Sager PT: Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline. J Clin Pharmacol 2006; 46:498-507.
17. U.S. Department of Health and Human Services, Food and Drug Administration: E14 Clinical Evaluation of QT/QTc. Interval Prolongation and. Proarrhythmic Potential for Non-Antiarrhythmic Drugs, 2005.
18. Drici MD, Clément N: Is gender a risk factor for adverse drug reactions?: The example of drug-induced long QT syndrome. Drug Saf 2001; 24:575-85.
19. Abi-Gerges N, Philp K, Pollard C, Wakefield I, Hammond TG, Valentin J-P: Sex differences in ventricular repolarization: From cardiac electrophysiology to Torsades de Pointes. Fundam Clin Pharmaco 2004;18:139-51.
20. Lehtonen A, Fodstad H, Laitinen-Forsblom P, Toivonen L, Kontula K, Swan H: Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes. Heart Rhythm 2007; 4:603-7.
21. Yang P, Kanki H, Drolet B, Yang T, Wei J, Viswanathan PC, Hohnloser SH, Shimizu W, Schwartz PJ, Stanton M, Murray KT, Norris K, George AL Jr, Roden DM: Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 2002; 105:1943-8.
22. Charbit B, Alvarez JC, Dasque E, Abe E, Dmolis JL, Funck-Brentano C: Droperidol and ondansetron-induced QT interval prolongation: A clinical drug interaction study. Anesthesiology 2008; 109:206-12.
23. Nuttall GA, Eckerman KM, Jacob KA, Pawlaski EM, Wigersma SK, Marienau ME, Oliver WC, Narr BJ, Ackerman MJ: Does low-dose droperidol administration increase the risk of druginduced QT prolongation and torsade de pointes in the general surgical population? Anesthesiology 2007; 107: 531-6.
24. White PF, Song D, Abrao J, Klein KW, Navarette B: Effect of low-dose droperidol on the QT interval during and after general anesthesia: A placebo-controlled study. Anesthesiology 2005; 102:1101-5.
25. Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, Philippides GJ, Roden DM, Zareba W, American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, Council on Cardiovascular Nursing, American College of Cardiology Foundation: Prevention of torsade de pointes in hospital settings: A scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2010; 55:934-47.
26. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent GM, Garson A, Jr: The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 1991; 84:1136-44.
27. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ: Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998; 339: 960-5.
28. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D: Risk stratification in the long-QT syndrome. N Engl J Med 2003; 348:1866-74.
29. Pickham D, Helfenbein E, Shinn JA, Chan G, Funk M, Weinacker A, Liu JN, Drew BJ: High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: Results of the QT in Practice (QTIP) Study. Crit Care Med 2012; 40:394-9.
30. Chapel S, Hutmacher MM, Bockbrader H, de Greef R, Lalonde RL: Comparison of QTc data analysis methods recommended by the ICH E14 guidance and exposure-response analysis: Case study of a thorough QT study of asenapine Clin Pharmacol Ther 2011; 89:75-80